Behavioral and cardiovascular changes in the chronic mild stress model of depression

Physiology and Behavior

Volumn 78, Issue 4-5, 2003, Pages 703-710

  Grippo, Angela J ^a,b   Beltz, Terry G ^a   Johnson, Alan Kim ^a,b,c  

^a The University of Iowa   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

Anhedonia; Heart rate; Locomotor activity; Rats; Sympathetic nervous system

Indexed keywords

SUCROSE;

ADRENERGIC SYSTEM; ANHEDONIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR SYSTEM; CLINICAL PROTOCOL; DEPRESSION; DIETARY INTAKE; DISEASE SEVERITY; HEART RATE; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STRESS;

EID: 0012611753     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9384(03)00050-7     Document Type: Article

References (37)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders. 4th ed. 1994;American Psychiatric Association, Washington (DC).
2. Siever L.J. Role of noradrenergic mechanisms in the etiology of the affective disorders. Meltzer H.Y. Psychopharmacology: the third generation of progress. 1987;493-504 Raven Press, New York.
3. Meltzer H.Y. Role of serotonin in depression. Ann. N.Y. Acad. Sci. 600:1990;486-499.
4. Asnis G.M., Halbreich U., Ryan N.D., Rabinowicz H., Puig-Antich J., Nelson B.et al. The relationship of the dexamethasone suppression test (1 mg and 2 mg) to basal plasma cortisol levels in endogenous depression. Psychoneuroendocrinology. 12:1987;295-301.
5. Nemeroff C.B., Widerlöv E., Bissette G., Walléus H., Karlsson I., Eklund K.et al. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science. 226:1984;1342-1344.
6. Spriggs D.R., Sherman M.L., Michie H., Arthor K.A., Imamura K., Wilmore D.et al. Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion. A phase 1 and pharmacology study. J. Natl. Cancer Inst. 80:1988;1039-1044.
7. Cunningham E.T. Jr., De Souza E.B. Interleukin 1 receptors in the brain and endocrine tissues. Immunol. Today. 14:1993;171-176.
8. Lahmeyer H.W., Bellur S.N. Cardiac regulation and depression. J. Psychiatr. Res. 21:1987;1-6.
9. Carney R.M., Saunders R.D., Freedland K.E., Stein P., Rich M.W., Jaffe A.S. Association of depression with reduced heart rate variability in coronary artery disease. Am. J. Cardiol. 76:1995;562-564.
10. Moreau J.-L., Jenck F., Martin J.R., Mortas P., Haefely W.E. Antidepressant treatment prevents chronic unpredictable mild stress-induced anhedonia as assessed by ventral tegmentum self-stimulation behavior in rats. Eur. Neuropsychopharmacol. 2:1992;43-49.
11. Willner P., Sampson D., Papp M., Phillips G., Muscat R. Animal models of anhedonia. Soubrié P. Anxiety, depression, and mania. Animal models of psychiatric disorders. 1991;71-99 Karger, Basel.
12. Willner P., Towell A., Sampson D., Sophokleous S., Muscat R. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology. 93:1987;358-364.
13. Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology. 134:1997;319-329.
14. Willner P. The validity of animal models of depression. Psychopharmacology. 83:1984;1-16.
15. Gorka Z., Moryl E., Papp M. Effect of chronic mild stress on circadian rhythms in the locomotor activity in rats. Pharmacol. Biochem. Behav. 54:1996;229-234.
16. Cheeta S., Ruigt G., van Proosdij J., Willner P. Changes in sleep architecture following chronic mild stress. Biol. Psychiatry. 41:1997;419-427.
17. D'Aquila P.S., Brain P., Willner P. Effects of chronic mild stress on performance in behavioural tests relevant to anxiety and depression. Physiol. Behav. 56:1994;861-867.
18. Muscat R., Papp M., Willner P. Antidepressant-like effects of dopamine agonist in an animal model of depression. Biol. Psychiatry. 31:1992;937-946.
19. Muscat R., Papp M., Willner P. Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline. Psychopharmacology. 109:1992;433-438.
20. Grippo A.J., Moffitt J.A., Johnson A.K. Cardiovascular alterations and autonomic imbalance in an experimental model of depression. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282:2002;R1333-R1341.
21. Sampson D., Willner P., Muscat R. Reversal of antidepressant action by dopamine antagonists in an animal model of depression. Psychopharmacology. 104:1991;491-495.
22. Monleon S., D'Aquila P., Parra A., Simon V.M., Brain P.F., Willner P. Attenuation of sucrose consumption in mice by chronic mild stress and its restoration by imipramine. Psychopharmacology. 117:1995;453-457.
23. Katz R.J., Roth K.A., Carroll B.J. Acute and chronic stress effects on open field activity in the rat: implications for a model of depression. Neurosci. Biobehav. Rev. 5:1981;247-251.
24. Barr A.M., Phillips A.G. Chronic mild stress has no effect on responding by rats for sucrose under a progressive ratio schedule. Physiol. Behav. 64:1998;591-597.
25. Perlini S., Giangregorio F., Coco M., Radaelli A., Solda P.L., Bernardi L.et al. Autonomic and ventilatory components of heart rate and blood pressure variability in freely behaving rats. Am. J. Physiol. Heart Circ. Physiol. 269:1995;H1729-H1734.
26. Task Force of the European Society of Cardiology, North American Society of Pacing and Electrophysiology Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation. 93:1996;1043-1065.
27. Loas G. Vulnerability to depression: a model centered on anhedonia. J. Affect. Disord. 41:1996;39-53.
28. Solberg L.C., Horton T.H., Turek F.W. Circadian rhythms and depression: effects of exercise in an animal model. Am. J. Physiol. Regul. Integr. Comp. Physiol. 276:1999;R152-R161.
29. Lechin F., van der Dijs B., Orozco B., Lechin M.E., Báez S., Lechin A.E.et al. Plasma neurotransmitters, blood pressure, and heart rate during supine-resting, orthostasis, and moderate exercise conditions in major depressed patients. Biol. Psychiatry. 38:1995;166-173.
30. Carney R.M., Rich M.W., teVelde A., Saini J., Clark K., Freedland K.E. The relationship between heart rate, heart rate variability and depression in patients with coronary artery disease. J. Psychosom. Res. 32:1988;159-164.
31. Krittayaphong R., Cascio W.E., Light K.C., Sheffield D., Golden R.N., Finkel J.B.et al. Heart rate variability in patients with coronary artery disease: differences in patients with higher and lower depression scores. Psychosom. Med. 59:1997;231-235.
32. Anda R., Williamson D., Jones D., Macera C., Eaker E., Glassman A.et al. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults. Epidemiology. 4:1993;285-294.
33. Penninx B.W.J.H., Beekman A.T.F., Honig A., Deeg D.J.H., Schoevers R.A., van Eijk J.T.M.et al. Depression and cardiac mortality: results from a community-based longitudinal study. Arch. Gen. Psychiatry. 58:2001;221-227.
34. Lebovits B.Z., Shekelle R.B., Ostfeld A.M., Paul O. Prospective and retrospective psychological studies of coronary heart disease. Psychosom. Med. 29:1967;265-272.
35. Greene W.A., Goldstein S., Moss A.J. Psychosocial aspects of sudden death. A preliminary report. Arch. Intern. Med. 129:1972;725-731.
36. Barefoot J.C., Helms M.J., Mark D.B., Blumenthal J.A., Califf R.M., Haney T.L.et al. Depression and long-term mortality risk in patients with coronary artery disease. Am. J. Cardiol. 78:1996;613-617.
37. Post R.M. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am. J. Psychiatry. 149:1992;999-1010.